Dana-Farber -- Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT.
